Literature DB >> 25833026

Differential response of glial fibrillary acidic protein-positive astrocytes in the rat prefrontal cortex following ethanol self-administration.

Cecilia Bull1, Wahab A Syed, Sabrina C Minter, M Scott Bowers.   

Abstract

BACKGROUND: Prefrontal cortex (PFC) dysfunction is believed to contribute to the transition from controlled substance use to abuse. Because astrocytes have been suggested to play a key role in the development and maintenance of drug-seeking behaviors, we sought to determine whether PFC astrocytes are affected by ethanol (EtOH) self-administration.
METHODS: EtOH consumption was modeled in rats by 3 self-administration paradigms where EtOH was made concurrently available with water in the home cage either continuously (CEA) or intermittently (IEA). In the third paradigm, EtOH was only available in the operant chamber (OEA). To avoid the potential confound of acute EtOH effects, all rats were sacrificed after either 24-hour or 3-week abstinence. In all groups, the effect of EtOH consumption on PFC astrocytes was measured using unbiased stereological counting of cells expressing the astrocyte marker glial fibrillary acidic protein (GFAP). GFAP immunoreactivity commonly changes in response to pharmacological insult or injury.
RESULTS: GFAP-positive astrocyte number increased in the prelimbic and anterior cingulate cortex regions of the PFC after IEA. No change was found in the infralimbic or orbitofrontal cortex after IEA. After 3-week abstinence, there was a reduction of astrocytes in the prelimbic and orbitofrontal cortex of the CEA cohort as well as a reduction in the orbitofrontal cortex of the OEA cohort.
CONCLUSIONS: These findings demonstrate that discrete PFC subregions contain GFAP-positive astrocyte populations that respond differentially to distinct EtOH consumption paradigms. A better understanding of how specific astrocyte populations uniquely adapt to EtOH consumption could provide insight for targeted therapeutic interventions.
Copyright © 2015 by the Research Society on Alcoholism.

Entities:  

Keywords:  Astrocyte; Glial Fibrillary Acidic Protein; Prefrontal Cortex; Self-Administration; Stereology

Mesh:

Substances:

Year:  2015        PMID: 25833026      PMCID: PMC4384186          DOI: 10.1111/acer.12683

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  46 in total

Review 1.  Design-based stereology in neuroscience.

Authors:  C Schmitz; P R Hof
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

Review 2.  Behavioural assessment of drug reinforcement and addictive features in rodents: an overview.

Authors:  Carles Sanchis-Segura; Rainer Spanagel
Journal:  Addict Biol       Date:  2006-03       Impact factor: 4.280

3.  Reduced glial and neuronal packing density in the orbitofrontal cortex in alcohol dependence and its relationship with suicide and duration of alcohol dependence.

Authors:  Jose J Miguel-Hidalgo; James C Overholser; Herbert Y Meltzer; Craig A Stockmeier; Grazyna Rajkowska
Journal:  Alcohol Clin Exp Res       Date:  2006-11       Impact factor: 3.455

4.  Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator.

Authors:  M J West; L Slomianka; H J Gundersen
Journal:  Anat Rec       Date:  1991-12

5.  The unbiased estimation of number and sizes of arbitrary particles using the disector.

Authors:  D C Sterio
Journal:  J Microsc       Date:  1984-05       Impact factor: 1.758

6.  Lower packing density of glial fibrillary acidic protein-immunoreactive astrocytes in the prelimbic cortex of alcohol-naive and alcohol-drinking alcohol-preferring rats as compared with alcohol-nonpreferring and Wistar rats.

Authors:  Jose Javier Miguel-Hidalgo
Journal:  Alcohol Clin Exp Res       Date:  2005-05       Impact factor: 3.455

Review 7.  The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive.

Authors:  P S Goldman-Rakic
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1996-10-29       Impact factor: 6.237

8.  Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics.

Authors:  Sabine M Grüsser; Jana Wrase; Sabine Klein; Derik Hermann; Michael N Smolka; Matthias Ruf; Wolfgang Weber-Fahr; Herta Flor; Karl Mann; Dieter F Braus; Andreas Heinz
Journal:  Psychopharmacology (Berl)       Date:  2004-09       Impact factor: 4.530

9.  Neuronal degeneration in rat cerebrocortical and olfactory regions during subchronic "binge" intoxication with ethanol: possible explanation for olfactory deficits in alcoholics.

Authors:  M A Collins; T D Corso; E J Neafsey
Journal:  Alcohol Clin Exp Res       Date:  1996-04       Impact factor: 3.455

10.  Ethanol self-infusion into the ventral tegmental area by alcohol-preferring rats.

Authors:  G J Gatto; W J McBride; J M Murphy; L Lumeng; T K Li
Journal:  Alcohol       Date:  1994 Nov-Dec       Impact factor: 2.405

View more
  16 in total

Review 1.  Cross-species molecular dissection across alcohol behavioral domains.

Authors:  Sean P Farris; Brien P Riley; Robert W Williams; Megan K Mulligan; Michael F Miles; Marcelo F Lopez; Robert Hitzemann; Ovidiu D Iancu; Alexander Colville; Nicole A R Walter; Priscila Darakjian; Denesa L Oberbeck; James B Daunais; Christina L Zheng; Robert P Searles; Shannon K McWeeney; Kathleen A Grant; R Dayne Mayfield
Journal:  Alcohol       Date:  2017-12-06       Impact factor: 2.405

Review 2.  The neuroimmune transcriptome and alcohol dependence: potential for targeted therapies.

Authors:  Anna Warden; Emma Erickson; Gizelle Robinson; R Adron Harris; R Dayne Mayfield
Journal:  Pharmacogenomics       Date:  2016-12-05       Impact factor: 2.533

Review 3.  Neuroinflammation in addiction: A review of neuroimaging studies and potential immunotherapies.

Authors:  Milky Kohno; Jeanne Link; Laura E Dennis; Holly McCready; Marilyn Huckans; William F Hoffman; Jennifer M Loftis
Journal:  Pharmacol Biochem Behav       Date:  2019-01-26       Impact factor: 3.533

Review 4.  Disentangling the Role of Astrocytes in Alcohol Use Disorder.

Authors:  Louise Adermark; M Scott Bowers
Journal:  Alcohol Clin Exp Res       Date:  2016-08-01       Impact factor: 3.455

Review 5.  Astrocyte regulation of synaptic signaling in psychiatric disorders.

Authors:  Anna Kruyer; Peter W Kalivas; Michael D Scofield
Journal:  Neuropsychopharmacology       Date:  2022-05-16       Impact factor: 7.853

6.  Cocaine Self-Administration and Extinction Leads to Reduced Glial Fibrillary Acidic Protein Expression and Morphometric Features of Astrocytes in the Nucleus Accumbens Core.

Authors:  Michael D Scofield; Hao Li; Benjamin M Siemsen; Kati L Healey; Phuong K Tran; Nicholas Woronoff; Heather A Boger; Peter W Kalivas; Kathryn J Reissner
Journal:  Biol Psychiatry       Date:  2015-12-31       Impact factor: 13.382

7.  Adolescent Intermittent Alcohol Exposure: Dysregulation of Thrombospondins and Synapse Formation are Associated with Decreased Neuronal Density in the Adult Hippocampus.

Authors:  Mary-Louise Risher; Hannah G Sexton; W Christopher Risher; Wilkie A Wilson; Rebekah L Fleming; Roger D Madison; Scott D Moore; Cagla Eroglu; H Scott Swartzwelder
Journal:  Alcohol Clin Exp Res       Date:  2015-11-05       Impact factor: 3.455

Review 8.  Neuroimmune signaling in alcohol use disorder.

Authors:  Emma K Erickson; Emily K Grantham; Anna S Warden; R A Harris
Journal:  Pharmacol Biochem Behav       Date:  2018-12-24       Impact factor: 3.533

9.  Tyramine synthesis, vesicular packaging, and the SNARE complex function coordinately in astrocytes to regulate Drosophila alcohol sedation.

Authors:  Kristen M Lee; Ananya Talikoti; Keith Shelton; Mike Grotewiel
Journal:  Addict Biol       Date:  2021-02-03       Impact factor: 4.280

Review 10.  Astroglial correlates of neuropsychiatric disease: From astrocytopathy to astrogliosis.

Authors:  Ronald Kim; Kati L Healey; Marian T Sepulveda-Orengo; Kathryn J Reissner
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-10-06       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.